Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00952900 · ClinicalTrials.gov registry record · NA
An Implementation and Biobehavioral Study of Temporomandibular Joint and Muscle Disorder (TMJMD)
A NA study, sponsored by The University of Texas at Arlington.
- Completed
- Registry status
- NA
- Development phase
- 456
- Enrollment target
NCT00952900 is a NA study that has completed, run by The University of Texas at Arlington. The registered enrollment target is 456 participants.
The verdict
NCT00952900, a NA study, has completed, sponsored by The University of Texas at Arlington.
- COMPLETED
- Registry status
- NA
- Development phase
- 456 participants
- Enrollment target
Study Summary
With the great economic costs and traditionally poor outcomes among chronic temporomandibular joint and muscle disorder (TMJMD) patients, it has become important to treat patients in the acute state, in order to prevent these more chronic disability problems. This has been the goal of two past funded grant projects. Results of the initial project isolated risk factors that successfully predicted the development of chronicity with a 91% accuracy rate. A statistical algorithm was developed which was used in the second project to screen out "high-risk" patients. These patients were then randomly assigned an early intervention or non-intervention group. One-year follow-up evaluations documented the treatment efficacy and cost effectiveness of early intervention. These results have major implications for effective early intervention and significant health care cost savings for this prevalent pain and disability problem. For the present proposed project, we plan to implement this treatment program in order to evaluate its effectiveness in more community-based dental practices. This is in response to NIH's request for the implementation of evidence-based treatment approaches, developed in controlled clinical settings, to the "real world" of diverse practices in the community. Acute TMJMD patients will be recruited from two community-based clinics. Based upon our "risk" screening algorithm, high-risk patients will be randomly assigned to one of two groups (n=225/group): an early biobehavioral intervention or an attention-control group. It is hypothesized that the attention control "high-risk" patients will display more chronic TMJMD problems, relative to the "high-risk" early intervention patients, at one- and two-year follow-ups. A number of biopsychosocial measures will be evaluated, including chewing performance, the RDC/TMD, self-reported pain and stress, etc. Such a multi-level, multi-systems approach has not been applied to better understand the biopsychosocial underp
Interventions
- BEHAVIORAL Biobehavioral
- BEHAVIORAL Active Coping/Attention Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 456 participants |
| Start Date | 2008-08 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00952900
The ClinicalTrials.gov registry entry for NCT00952900 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 456 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas at Arlington, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Biobehavioral is the first listed.
NCT00952900 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00952900 about?
NCT00952900 is a clinical study titled "An Implementation and Biobehavioral Study of Temporomandibular Joint and Muscle Disorder (TMJMD)". With the great economic costs and traditionally poor outcomes among chronic temporomandibular joint and muscle disorder (TMJMD) patients, it has become important to treat patients in the acute state, in order to prevent these more chronic disability problems. This has been the goal of two past funde...
What is the current status of trial NCT00952900?
This trial is currently completed. It is a NA study. The enrollment target is 456 participants. The study started on 2008-08. Estimated completion is 2014-07.
What interventions are being tested in trial NCT00952900?
The interventions under investigation include: Biobehavioral (BEHAVIORAL), Active Coping/Attention Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00952900?
This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.